摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-epi-crassalactone D | 918906-87-3

中文名称
——
中文别名
——
英文名称
8-epi-crassalactone D
英文别名
(+)-crassalactone D;crassalactone D;(5S,7R,8S)-8-hydroxy-7-phenyl-1,6-dioxaspiro[4.4]non-3-en-2-one
8-epi-crassalactone D化学式
CAS
918906-87-3
化学式
C13H12O4
mdl
——
分子量
232.236
InChiKey
HQBGZDWOMDYFLH-UHTWSYAYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    509.7±50.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:46984832d42b3c6ba8c8a346243b6882
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Asymmetric Total Synthesis of (+)-Crassalactone D
    作者:Zhicai Yang、Phung Tang、Jolicia F. Gauuan、Bruce F. Molino
    DOI:10.1021/jo902055b
    日期:2009.12.18
    The asymmetric total synthesis of (+)-crassalactone D (4), a naturally occurring antitumor agent, has been achieved by employing an oxidative spirocyclization of furan 11 as the key step. Two close analogues, 7-epi-crassalactone D (14) and 5-epi-7-epi-crassalactone D (15), also have been prepared in the course of the synthesis of (+)-crassalactone D.
    通过将呋喃11的氧化螺环化作为关键步骤,已经实现了自然生成的抗肿瘤药(+)-cr内酯D(4)的不对称全合成。在合成(+)-assa内酯D的过程中,还制备了两个紧密的类似物7- Epi- cr内酯D(14)和5- epi -7- epi内酯D(15)。
  • Divergent Synthesis of Cytotoxic Styryl Lactones Related to Goniobutenolides A and B, and to Crassalactone D
    作者:Velimir Popsavin、Ivana Kovačević、Goran Benedeković、Mirjana Popsavin、Vesna Kojić、Gordana Bogdanović
    DOI:10.1021/ol302860z
    日期:2012.12.7
    Goniobutenolides A (1) and B (2), crassalactone D (3), 4-epi-crassalactone D (4), and the corresponding 7-epimers have been synthesized starting from d-glucose. The key step in the synthesis of 1 and 2 is a new one-pot sequence comprised of a Z-selective Wittig olefination/lactonization/β-elimination. Preparation of 3 and 4 included the final 5-endo-trig spirocyclization of 1 and 2. The synthesized
    从d-葡萄糖开始合成了Goniobutenolides A(1)和B(2),crassalactone D(3),4- epi- crassalactone D(4)和相应的7表位受体。合成1和2的关键步骤是一个新的一锅法序列,该序列由Z选择性维蒂希烯化/内酯化/β-消除反应组成。3和4的制备包括1和2的最终5-内-trig螺环化。评价合成产物对所选肿瘤细胞系的体外抗增殖活性。
  • Synthesis and in vitro antitumour activity of crassalactone D, its stereoisomers and novel cinnamic ester derivatives
    作者:Ivana Kovačević、Mirjana Popsavin、Goran Benedeković、Jelena Kesić、Vesna Kojić、Dimitar Jakimov、Tatjana Srdić-Rajić、Gordana Bogdanović、Vladimir Divjaković、Velimir Popsavin
    DOI:10.1016/j.ejmech.2017.03.088
    日期:2017.7
    Naturally occurring styryl lactone, crassalactone D (1), unnatural 4-epi-crassalactone D (2), and the corresponding 7-epimers (3 and 4) have been synthesized starting from d-glucose. The key step of the synthesis is a new one-pot sequence that commenced with a Z-selective Wittig olefination of suitably functionalized sugar lactols with a stabilized ylide, (methoxycarbonylmethylene)-triphenylphosphorane
    从d-葡萄糖开始合成了天然存在的苯乙烯基内酯,crassalactone D(1),非天然的4-ep-crassalactone D(2)和相应的7-表位(3和4)。合成的关键步骤是一个新的一锅法序列,该序列首先在适当的官能化糖乳糖醇与Z选择性Wittig烯烃与稳定的内酯,(甲氧基羰基亚甲基)-三苯基膦烷的无水甲醇中进行烯化,以得到1或3。与相应的4受体(分别为2或4)的混合物。已经制备了许多苯乙烯基内酯1-4的6-O-肉桂酰基衍生物,它们在肉桂酸残基的C-4位具有给电子或吸电子功能。评估了合成产物对选定的人类肿瘤细胞系的体外抗增殖活性,因此,在许多情况下都记录了非常强的细胞毒性。SAR分析表明,一些重要的生物活性结构特征,例如C-4和C-7位置的立体化学,以及肉桂酸酯部分芳环C-4位置的取代基的性质。流式细胞仪和蛋白质印迹分析数据提供了对合成化合物抗增殖作用的潜在机制的深入了解。
  • Synthesis and antiproliferative activity of goniobutenolides A and B, 5-halogenated crassalactone D derivatives and the corresponding 7-epimers
    作者:Ivana Kovačević、Mirjana Popsavin、Goran Benedeković、Vesna Kojić、Dimitar Jakimov、Marko V. Rodić、Tatjana Srdić-Rajić、Gordana Bogdanović、Vladimir Divjaković、Velimir Popsavin
    DOI:10.1016/j.ejmech.2015.12.011
    日期:2016.1
    A new synthesis of goniobutenolides A (1) and B (2) and the corresponding 7-epimers has been achieved starting from diacetone D-glucose. The key step of the synthesis is a new one-pot sequence that commenced with Z-selective Wittig (or Horner-Wadsworth-Emmons) olefination, followed by successive gamma-lactonisation and beta-elimination. The above-mentioned unsaturated lactones were then converted to the corresponding 5-halogenated crassalactone D derivatives by using the appropriate haloetherification protocol. The most of synthesized compounds exhibited potent cytotoxic activities against a panel of tumour cell lines. The main structural features responsible for their antitumour potency have been revealed by means of SAR analysis. Flow cytometry data suggested that cytotoxic effects of these compounds in the culture of K562 cells might be mediated by apoptosis, additionally revealing that these molecules induced changes in cell cycle distribution of these cells. Results of semi-quantitative Western blot analysis indicate that the most of synthesized compounds induce apoptosis in a caspase-dependent manner. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Galan-Fernandez, Raquel; Clemente-Tejeda, David; Bermejo, Francisco A., ARKIVOC, 2012, vol. 2012, # 9, p. 1 - 14
    作者:Galan-Fernandez, Raquel、Clemente-Tejeda, David、Bermejo, Francisco A.
    DOI:——
    日期:——
查看更多